314 related articles for article (PubMed ID: 26491157)
1. Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.
Zolla-Pazner S; Cohen SS; Boyd D; Kong XP; Seaman M; Nussenzweig M; Klein F; Overbaugh J; Totrov M
J Virol; 2016 Jan; 90(2):636-49. PubMed ID: 26491157
[TBL] [Abstract][Full Text] [Related]
2. Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.
Powell RLR; Totrov M; Itri V; Liu X; Fox A; Zolla-Pazner S
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615206
[TBL] [Abstract][Full Text] [Related]
3. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.
Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P
mBio; 2018 Dec; 9(6):. PubMed ID: 30538178
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms regulate exposure of neutralizing epitopes in the V2 and V3 loops of HIV-1 envelope.
Upadhyay C; Mayr LM; Zhang J; Kumar R; Gorny MK; Nádas A; Zolla-Pazner S; Hioe CE
J Virol; 2014 Nov; 88(21):12853-65. PubMed ID: 25165106
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
Moyo T; Ereño-Orbea J; Jacob RA; Pavillet CE; Kariuki SM; Tangie EN; Julien JP; Dorfman JR
J Virol; 2018 Jul; 92(14):. PubMed ID: 29618644
[TBL] [Abstract][Full Text] [Related]
6. Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.
Dutta M; Liu J; Roux KH; Taylor KA
J Virol; 2014 Nov; 88(21):12265-75. PubMed ID: 25122783
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.
Hioe CE; Kumar R; Upadhyay C; Jan M; Fox A; Itri V; Peachman KK; Rao M; Liu L; Lo NC; Tuen M; Jiang X; Kong XP; Zolla-Pazner S
Front Immunol; 2018; 9():2441. PubMed ID: 30416503
[TBL] [Abstract][Full Text] [Related]
8. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
9. epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals.
Tang H; Robinson JE; Gnanakaran S; Li M; Rosenberg ES; Perez LG; Haynes BF; Liao HX; Labranche CC; Korber BT; Montefiori DC
J Virol; 2011 Sep; 85(18):9286-99. PubMed ID: 21734041
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
[TBL] [Abstract][Full Text] [Related]
11. The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12.
Chaillon A; Braibant M; Moreau T; Thenin S; Moreau A; Autran B; Barin F
J Virol; 2011 Apr; 85(7):3642-8. PubMed ID: 21248038
[TBL] [Abstract][Full Text] [Related]
12. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
[TBL] [Abstract][Full Text] [Related]
13. Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.
Shen G; Upadhyay C; Zhang J; Pan R; Zolla-Pazner S; Kong XP; Hioe CE
PLoS One; 2015; 10(10):e0141233. PubMed ID: 26491873
[TBL] [Abstract][Full Text] [Related]
14. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
[TBL] [Abstract][Full Text] [Related]
15. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies.
Rusert P; Krarup A; Magnus C; Brandenberg OF; Weber J; Ehlert AK; Regoes RR; Günthard HF; Trkola A
J Exp Med; 2011 Jul; 208(7):1419-33. PubMed ID: 21646396
[TBL] [Abstract][Full Text] [Related]
17. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
Moody MA; Gao F; Gurley TC; Amos JD; Kumar A; Hora B; Marshall DJ; Whitesides JF; Xia SM; Parks R; Lloyd KE; Hwang KK; Lu X; Bonsignori M; Finzi A; Vandergrift NA; Alam SM; Ferrari G; Shen X; Tomaras GD; Kamanga G; Cohen MS; Sam NE; Kapiga S; Gray ES; Tumba NL; Morris L; Zolla-Pazner S; Gorny MK; Mascola JR; Hahn BH; Shaw GM; Sodroski JG; Liao HX; Montefiori DC; Hraber PT; Korber BT; Haynes BF
Cell Host Microbe; 2015 Sep; 18(3):354-62. PubMed ID: 26355218
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
[TBL] [Abstract][Full Text] [Related]
19. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
[TBL] [Abstract][Full Text] [Related]
20. Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.
Utachee P; Isarangkura-na-ayuthaya P; Tokunaga K; Ikuta K; Takeda N; Kameoka M
Retrovirology; 2014 Apr; 11():32. PubMed ID: 24758333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
